MedPath
HSA Approval

DOBUTAMINE INJECTION 12.5 mg/ml

SIN08702P

DOBUTAMINE INJECTION 12.5 mg/ml

DOBUTAMINE INJECTION 12.5 mg/ml

February 5, 1996

PFIZER PRIVATE LIMITED

PFIZER PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPFIZER PRIVATE LIMITED
Licence HolderPFIZER PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS

Medical Information

C01CA07

dobutamine

Manufacturer Information

PFIZER PRIVATE LIMITED

HOSPIRA INC

Active Ingredients

DOBUTAMINE HCl EQV DOBUTAMINE

12.5 mg/ml

Dobutamine

Documents

Package Inserts

Dobutamine injection PI.pdf

Approved: May 31, 2018

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DOBUTAMINE INJECTION 12.5 mg/ml - HSA Approval | MedPath